Patent details

EP2392336 Title: 24-norUDCA for treating autoimmune hepatitis

Basic Information

Publication number:
EP2392336
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111762712
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
24-norUDCA for treating autoimmune hepatitis
French Title of Invention:
24-norUDCA pour le traitement de l'hepatite auto-immune
German Title of Invention:
24-norUDCA zur Behandlung der Autoimmunhepatitis
SPC Number:

Dates

Filing date:
12/05/2005
Grant date:
22/06/2016
EP Publication Date:
22/06/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/12/2011
EP B1 Publication Date:
22/06/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/05/2020
Expiration date:
12/05/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/05/2005
 
 

Name:
Medizinische Universität Graz
Address:
Auenbruggerplatz 2, 8036 Graz, Austria (AT)

Agent

Name:
MARKS & CLERK LLP
From:
22/08/2016
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
Fickert Peter
Address:
Austria (AT)

2

Name:
Hofmann Alan
Address:
United States (US)

3

Name:
Trauner Michael
Address:
Austria (AT)

Classification

Main IPC Class:
A61K 31/575;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
21/05/2019
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
PAVIS GMBH
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56